Hot Sale Buserelin CAS 57982-77-1 For Treat Prostate cancer and breast cancer

Hot Sale Buserelin CAS 57982-77-1 For Treat Prostate cancer and breast cancer

Product Name: BUSERELIN
Synonyms: (d-ser(bu(supt)(sup6)))-lh-rh(1-9)nonapeptide-ethylamide;(d-ser(tbu)(sup6)-ea(sup10))-lhrh;(d-ser(tbu)(sup6)-ea(sup10))-luteinizinghormone-releasinghormon;(d-ser(tbu)(sup6)-ea(sup10))-luteinizinghormone-releasinghormone;BUSERELIN;1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-;Buserilin;BUSERELIN PH. EUR.
CAS: 57982-77-1
MF: C60H86N16O13
MW: 1239.42
EINECS: 261-061-9
Product Categories: hormones
Mol File: 57982-77-1.mol

Buserelin, a GnRH analogue. It can induce an increase in LH, FSH and sex hormone secretion at the beginning of use, and after 1 to 2 weeks it starts to produce the opposite effect, and sex hormone secretion can be reduced to depot level. It is mainly used clinically for prostate cancer and breast cancer. It is injected subcutaneously at the beginning [in men with Flutamide] and nasal spray is used for maintenance treatment.

Buserelin CAS 57982-77-1 Chemical Properties
alpha D20 -40.4° (c = 1 in dimethylacetamide)
Boiling point 845.19°C (rough estimate)
density 1.0711 (rough estimate)
refractive index 1.6200 (estimate)
solubility Sparingly soluble in water and in dilute acids.
pka 9.82±0.15(Predicted)

Function and Application of Buserelin CAS 57982-77-1
GnRH analogs. It can induce an increase in I. H, FSH and sex hormone secretion at the beginning of use, and after 1 to 2 weeks it starts to produce the opposite effect, and sex hormone secretion can be reduced to depot level. It is mainly used clinically for prostate cancer and breast cancer. It is injected subcutaneously at the beginning (in men with flutamide), and maintenance treatment is given by nasal spray.